Kindeva Capabilities Update September 2026: Fill/Finish

This presentation will provide an overview of Kindeva’s sterile fill finish capabilities, with a focus on its state-of-the-art Bridgeton site. The session will highlight the site’s advanced aseptic manufacturing infrastructure, automated filling technologies and scalable capacity designed to support clinical and commercial injectable products.

Attendees will learn how Kindeva partners with pharmaceutical and biotech companies to accelerate development timelines and deliver high-quality injectable therapies to patients.